Clinical trials
Recruiting Breast Neoplasms trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2013 | 1 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 6 |
| 2023 | 8 |
| 2024 | 13 |
| 2025 | 17 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 57 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The Netherlands Cancer Institute | 10 |
| Maastricht University Medical Center | 5 |
| UMC Utrecht | 5 |
| Amsterdam UMC, location VUmc | 3 |
| AstraZeneca | 2 |
| Daiichi Sankyo | 2 |
| Eli Lilly and Company | 2 |
| Erasmus Medical Center | 2 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| Isabelle Henskens | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 57 |
| Neoplasms | 7 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Head and Neck Neoplasms | 5 |
| Ovarian Neoplasms | 5 |
| Esophageal Neoplasms | 4 |
| Lung Neoplasms | 4 |
| Prostatic Neoplasms | 4 |
| Stomach Neoplasms | 4 |
| Triple Negative Breast Neoplasms | 4 |
Trials
Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.